A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/29/1999	EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof
12/29/1999	EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999	EP0437547B1 Monoclonal antibodies against receptor-induced binding sites on ligands binding to proteins of the cytoadhesin super family
12/29/1999	CN1240001A Mutants of streptococcal toxin C and methods of use
12/29/1999	CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods
12/29/1999	CN1239675A Anti-tumor agent comprising salmosin as active ingredient
12/29/1999	CN1047794C Recombination double-cistron expressing plasmid, and its preparing process and use
12/29/1999	CA2618288A1 Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues
12/29/1999	CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999	CA2336192A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999	CA2336102A1 Absorptive hypercalciuria locus on human chromosome 1
12/29/1999	CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors
12/29/1999	CA2335978A1 Compounds of unstable dipeptidyl peptidase iv inhibitors
12/29/1999	CA2335793A1 A method for in vitro maturation of human gametes
12/29/1999	CA2335636A1 Sticking plaster for controlled release of natural interferon
12/29/1999	CA2335632A1 Assay to indicate the presence of non-fertilisable ova
12/29/1999	CA2335471A1 Compositions and methods for inhibiting bone resorption
12/29/1999	CA2334550A1 Method and compositions for the treatment or amelioration of female sexual dysfunction
12/29/1999	CA2333750A1 Adjuvant therapy
12/29/1999	CA2332122A1 Substituted cyclooctadepsipeptides
12/29/1999	CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
12/29/1999	CA2331919A1 Structured antisense nucleic acid molecules
12/29/1999	CA2331888A1 Novel staphylococcus peptides for bacterial interference
12/29/1999	CA2331782A1 Tissue-specific and target rna-specific ribozymes
12/29/1999	CA2331769A1 Prostate cancer-associated genes
12/29/1999	CA2331761A1 Tumor antigen peptides originating in cyclophilin b
12/29/1999	CA2331326A1 Human glycoprotease-like proteins and dnas encoding these proteins
12/29/1999	CA2331152A1 Cell cycle regulating factor
12/29/1999	CA2330542A1 Human arf-related proteins
12/29/1999	CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999	CA2330026A1 Compositions and methods for delivery of agents for altering neuronal growth, regeneration, and survival
12/29/1999	CA2329939A1 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof
12/29/1999	CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999	CA2328457A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
12/29/1999	CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999	CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999	CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/29/1999	CA2273408A1 Phytage formulation
12/28/1999	USRE36476 Administering topically to said mammal at the site of said microvascular anastomoses contemporaneously with microvascular reconstruction a small but inhibitory effective amount of tissue factor pathway inhibitors
12/28/1999	US6008367 Intermediate for synthesis of anticoagulant agents
12/28/1999	US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin
12/28/1999	US6008344 An oligonucleotide targeted to the coding region of the untranslated regions; therapy for alzheimer's disease
12/28/1999	US6008343 Nucleotide sequence with oligonucleotide regions which are sufficiently complementary to hybridize to target rna sequences; gene therapy; viricides; fungicides; bactericides; for plants, humans, and animals
12/28/1999	US6008340 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules
12/28/1999	US6008339 An oligonucleotide encoding a polypeptide, dor3, that induces dorsal and neural tissue development in vertebrates; therapy and diagnosis of alzheimer's/parkinson's/huntington's chorea, congenital diseases, anticarcinogenic/wound healing agents
12/28/1999	US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999	US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999	US6008333 Preparation of glucosaminyl muramic acid derivatives
12/28/1999	US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999	US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent
12/28/1999	US6008322 Stanniocalcin-2
12/28/1999	US6008320 Elastase inhibitor and process for preparing the same
12/28/1999	US6008319 A permeability enhancing peptide that is free of cytokine activity and is joined to a delivery vehicle that targets tumors; therapy for increasing uptake of antitumor agents or tumor imaging agents
12/28/1999	US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999	US6008225 Derivatives of antibiotic GE2270 factors C2a, D2 and E
12/28/1999	US6008217 An enzyme inhibitor against interleukin-1b, for treating apoptosis-mediated diseases, including inflammatory diseases, autoimmune diseases, proliferative disorders, infectious diseases, and degenerative diseases
12/28/1999	US6008201 DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/28/1999	US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999	US6008196 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/28/1999	US6008195 Antimicrobial peptides and methods of use
12/28/1999	US6008194 Human preprotachykinin B
12/28/1999	US6008193 Methods of using human von Willebrand factor GPIb binding domain polypeptides
12/28/1999	US6008192 Hydrophilic binary systems for the administration of lipophilic compounds
12/28/1999	US6008190 Cobalt Schiff base compounds
12/28/1999	US6008189 Intravaginal preparation containing physiologically active peptide
12/28/1999	US6008188 Cytokine potentiator and pharmaceutical formulation for cytokine administration
12/28/1999	US6008187 A pill comprising sodium salicylate, and a pharmaceutically-acceptable oil for providing enhanced absorption of the polypeptide through the wall of the gastrointestinal tract
12/28/1999	US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999	US6008048 Antisense inhibition of EGR-1 expression
12/28/1999	US6008044 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
12/28/1999	US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999	US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999	US6008033 A herpes simplex virus-2 protease or diisopropylphosphate-liganded herpes simplex virus-2 protease in orthorhombic crystalline form; for computer models and screening for enzyme inhibitors as viricides
12/28/1999	US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999	US6008023 Producing a fusion protein by transforming a thioredoxin reductase-deficient escherichia with a nucleotide molecule encoding an antibody or fragment; culturing and expressing the antibody; isolating antibody from the cytoplasm
12/28/1999	US6008022 Human cytokine polypeptide
12/28/1999	US6008020 Brain-associated inhibitor of tissue-type plasminogen activator
12/28/1999	US6008019 Plasminogen activator from saliva of the vampire bat
12/28/1999	US6008018 ELL2, a new member of an ELL family of RNA polymerase II elongation factors
12/28/1999	US6008017 Human cardiac/brain tolloid-like protein
12/28/1999	US6008014 Method of making lipid metabolic pathway compositions
12/28/1999	US6008013 A dna which codes for a protein expressed in the lower proliferative or upper hypertrophic zones of long bone and embryonic vertebrae growth plates; therapy and diagnosis of genetic bone defects; antiarthritic agent
12/28/1999	US6008011 A nucleic acid; therapy for osteoporosis, rheumatic diseases; antiproliferative/anticarcinogenic/antiinflammatory agents; wound healing agents; immunosuppressants
12/28/1999	US6007995 Antisense inhibition of TNFR1 expression
12/28/1999	US6007991 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer
12/28/1999	US6007989 Methods of screening for compounds that derepress or increase telomerase activity
12/28/1999	US6007988 A library of dna sequences which encode zinc finger polypeptide binding motifs for display on viral particles; the dna sequences having random allocation of amino acids; for producing zinc finger molecules
12/28/1999	US6007986 Methods for anti-addictive narcotic analgesic activity screening
12/28/1999	US6007985 Macromolecule delivery method and composition
12/28/1999	US6007980 A method for detecting goodpasture antibodies in a biological fluid sample by mixing fluid sample with a peptide which codes for a human collagen; antibodies in sample binding to peptide in an immunoassay idicates antibodies are present
12/28/1999	US6007847 Methods for administering nutritional indium
12/28/1999	US6007840 Pharmaceutical compositions comprising cyclosporins
12/28/1999	US6007835 Transdermal matrix system
12/28/1999	US6007833 Crosslinkable macromers bearing initiator groups
12/28/1999	US6007821 Immunosuppression; organ transplants, insulin dependent diabetes
12/28/1999	US6007816 Reducing transmigration of lymphocytes through endothelium into lymph node or inflamed synovium by administering monoclonal antibody specifically binding to a hybridized mammalian dna encoded polypeptide
12/28/1999	US6007810 Chondroitinase compositions
12/28/1999	US6007808 Nutrient mixture of eubiotic bacteria and glutamine or glutamine-containing polypeptide
12/28/1999	US6007805 Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
12/28/1999	US6007804 Administering dosage of interleukin-6 (il-6) to prevent gout; side effect reduction

1 ... 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 ... 3163